Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301) (RASolve 301)

November 4, 2026 updated by: Revolution Medicines, Inc.

RASolve 301: Phase 3 Multicenter, Open Label, Randomized Study of RMC-6236 Versus Docetaxel in Patients With Previously Treated Locally Advanced or Metastatic RAS[MUT] NSCLC

The purpose of this study is to evaluate the safety and efficacy of a novel RAS(ON) inhibitor compared to docetaxel.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

This is a global, randomized, open-label, Phase 3 study designed to evaluate whether treatment with daraxonrasib will improve progression free survival (PFS) or overall survival (OS) compared to docetaxel chemotherapy in patients with NSCLC who were previously treated. Patients will be randomized in a 1:1 ratio to receive daraxonrasib or docetaxel chemotherapy.

Study Type

Interventional

Enrollment (Estimated)

590

Phase

  • Phase 3

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Revolution Medicines Study Director
  • Phone Number: 1-844-2-REVMED
  • Email: medinfo@revmed.com

Study Locations

    • New South Wales
      • Blacktown, New South Wales, Australia, 2148
        • Active, not recruiting
        • Blacktown Medical Oncology Research, Blacktown Hospital
      • Camperdown, New South Wales, Australia, 2050
        • Active, not recruiting
        • Chris O'Brien Lifehouse
      • Kogarah, New South Wales, Australia, 2217
        • Active, not recruiting
        • St. George Private Hospital Clinical Trials Unit
      • Waratah, New South Wales, Australia, 2298
        • Active, not recruiting
        • Calvary Mater Newcastle
    • Queensland
      • South Brisbane, Queensland, Australia, 4101
        • Active, not recruiting
        • Mater Misericordiae Limited
    • Victoria
      • Melbourne, Victoria, Australia, 3004
        • Active, not recruiting
        • Alfred House
    • Western Australia
      • Perth, Western Australia, Australia, 6009
        • Active, not recruiting
        • Sir Charles Gairdner Hospital
      • Edegem, Belgium, 2650
        • Active, not recruiting
        • UZA
      • Gilly, Belgium, 6060
        • Active, not recruiting
        • Grand Hôpital de Charleroi - Les Viviers
      • Kortrijk, Belgium, 8500
        • Active, not recruiting
        • AZ Groeninge
      • Leuven, Belgium, 3000
        • Active, not recruiting
        • UZ Leuven-Campus Gasthuisberg
      • Roeselare, Belgium, 8800
        • Active, not recruiting
        • AZ Delta
    • Belgium
      • Anderlecht, Belgium, Belgium, 1070
        • Active, not recruiting
        • Institut Jules Bordet
      • Brest, France, 29200
        • Active, not recruiting
        • CHU Brest - Hôpital Morvan
      • Gironde, France, 33076
        • Active, not recruiting
        • Institut Bergonie
      • Toulouse, France, 31059
        • Active, not recruiting
        • CHU de Toulouse - Hopital Larrey
    • Bas Rhin
      • Strasbourg, Bas Rhin, France, 67091
        • Active, not recruiting
        • CHU Strasbourg - Nouvel Hôpital Civil
    • Bouches-du-Rhône
      • Marseille, Bouches-du-Rhône, France, 13915
        • Active, not recruiting
        • Hopital Nord - CHU Marseille
    • Herault
      • Montpellier, Herault, France, 34298
        • Active, not recruiting
        • Institut régional du Cancer de Montpellier
    • Ille et Vilaine
      • Rennes, Ille et Vilaine, France, 35033
        • Active, not recruiting
        • CHU Rennes Hôpital Pontchaillou
    • Isere
      • La Tronche, Isere, France, 38700
        • Active, not recruiting
        • CHU de Grenoble - Hôpital Albert Michallon
    • Loire Atlantique
      • Saint-Herblain, Loire Atlantique, France, 44805
        • Active, not recruiting
        • CHU Nantes - Hôpital Guillaume et René Laënnec
      • Saint-Herblain, Loire Atlantique, France, 44805
        • Active, not recruiting
        • Institut de Cancerologie de l Ouest
    • Lyon
      • Léon, Lyon, France, 69008
        • Active, not recruiting
        • Centre Leon Berard
    • Nord
      • Lille, Nord, France, 59037
        • Active, not recruiting
        • Hopital Albert Calmette - CHU Lille
    • Paris
      • Paris, Paris, France, 75005
        • Active, not recruiting
        • Institut Curie-site de Paris
      • Paris, Paris, France, 75018
        • Active, not recruiting
        • Hôpital Bichat - Claude Bernard
    • Rhone
      • Bron, Rhone, France, 69677
        • Active, not recruiting
        • Hopital Louis Pradel
    • Val de Marne
      • Créteil, Val de Marne, France, 94000
        • Active, not recruiting
        • Centre Hospitalier Intercommunal de Créteil
    • Villejuif
      • Vaillant, Villejuif, France, 94800
        • Active, not recruiting
        • Institut Gustave Roussy
      • Baden, Germany, 73730
        • Active, not recruiting
        • Klinikum Esslingen GmbH
      • Berlin, Germany, 13125
        • Active, not recruiting
        • Evangelische Lungenklinik Berlin
    • Bavaria
      • Gauting, Bavaria, Germany, 82131
        • Active, not recruiting
        • Asklepios Fachkliniken Muenchen-Gauting
      • München, Bavaria, Germany, 81925
        • Active, not recruiting
        • Muenchen Klinik Bogenhausen
    • Hesse
      • Giesen, Hesse, Germany, 35392
        • Active, not recruiting
        • Universitaetsklinikum Giessen und Marburg GmbH Standort Giessen
      • Immenhausen, Hesse, Germany, 34376
        • Active, not recruiting
        • LKI Lungenfachklinik Immenhausen
    • Lower Saxony
      • Göttingen, Lower Saxony, Germany, 37075
        • Active, not recruiting
        • Universitaetsmedizin Goettingen
    • North Rhine-Westphalia
      • Essen, North Rhine-Westphalia, Germany, 45147
        • Active, not recruiting
        • Universitaetsklinikum Essen
    • Saxony
      • Dresden, Saxony, Germany, 01307
        • Active, not recruiting
        • Universitaetsklinikum Carl Gustav Carus TU Dresden
    • Schleswig-Holstein
      • Lübeck, Schleswig-Holstein, Germany, 23538
        • Active, not recruiting
        • Universitaetsklinikum Schleswig-Holstein - Campus Luebeck
    • Wuerttemberg
      • Baden, Wuerttemberg, Germany, 69469
        • Active, not recruiting
        • Thoraxklinik Heidelberg gGmbH
      • Hong Kong, Hong Kong
        • Active, not recruiting
        • Queen Mary Hospital
      • Hong Kong, Hong Kong
        • Active, not recruiting
        • Hong Kong United Oncology Centre
      • Lai Chi Kok, Hong Kong
        • Active, not recruiting
        • Princess Margaret Hospital
      • Shatin, Hong Kong, 00000
        • Active, not recruiting
        • The Chinese University of Hong Kong
      • Dublin, Ireland, 24
        • Active, not recruiting
        • Tallaght University Hospital
      • Dublin, Ireland, D09 V2N0
        • Active, not recruiting
        • Beaumont Hospital Cancer Clinical
      • Galway, Ireland, H91 YR71
        • Active, not recruiting
        • Galway University Hospital
    • Cork
      • Cork, Cork, Ireland, T12 DC4A
        • Active, not recruiting
        • Cork Univeristy Hospital
    • Dublin
      • Dublin, Dublin, Ireland, 7
        • Active, not recruiting
        • Mater Private Hospital
    • Limerick
      • Cork, Limerick, Ireland, V94 F858
        • Active, not recruiting
        • University Hospital Limerick
      • Rome, Italy, 00168
        • Active, not recruiting
        • Fondazione Policlinico Universitario Agostino Gemelli IRCCS
    • Milan
      • Monza, Milan, Italy, 20900
        • Active, not recruiting
        • Fondazione IRCCS San Gerardo dei Tintori
    • Milano
      • Milan, Milano, Italy, 20133
      • Milan, Milano, Italy, 21206
      • Milan, Milano, Italy, 20132
        • Active, not recruiting
        • Ospedale San Raffaele
      • Milan, Milano, Italy, 20141
        • Active, not recruiting
        • IEO Istituto Europeo di Oncologia
      • Rossano, Milano, Italy, 20089
        • Active, not recruiting
        • Istituto Clinico Humanitas
    • Napoli
      • Naples, Napoli, Italy, 80131
        • Active, not recruiting
        • Azienda Ospedaliera Universitaria- Università degli Studi della Campania "Luigi Vanvitelli"
      • Naples, Napoli, Italy, 80131
        • Active, not recruiting
        • Istituto Nazionale Tumori Fondazione G. Pascale
    • Parma
      • Parma, Parma, Italy, 43124
        • Active, not recruiting
        • Azienda Ospedaliero Universitaria di Parma
    • Perugia
      • Perugia, Perugia, Italy, 06132
        • Active, not recruiting
        • Azienda Ospedaliera di Perugia Ospedale S. Maria della Misericordia
    • Pisa
      • Pisa, Pisa, Italy, 56124
        • Active, not recruiting
        • Azienda Ospedaliero Universitaria Pisana (Presidio di Cisanello)
    • Roma
      • Roma, Roma, Italy, 00128
        • Active, not recruiting
        • Fondazione Policlinico Universitario Campus Bio-Medico*
      • Roma, Roma, Italy, 00144
        • Active, not recruiting
        • Istituto Nazionale dei Tumori Regina Elena IRCCS
    • Torino
      • Orbassano, Torino, Italy, 10043
        • Active, not recruiting
        • Azienda Ospedaliero-Universitaria S.Luigi Gonzaga
    • Verona
      • Verona, Verona, Italy, 37126
        • Active, not recruiting
        • Azienda Ospedaliera Universitaria Integrata Verona (Ospedale Borgo Trento)
    • Aichi-ken
      • Nagoya, Aichi-ken, Japan, 464-8681
        • Recruiting
        • Aichi Cancer Center Hospital
        • Contact:
          • Phone Number: 052-762-6111
      • Toyoake-shi, Aichi-ken, Japan, 470-1192
        • Recruiting
        • Fujita Health University Hospital
        • Contact:
          • Phone Number: 0562-93-2111
    • Chiba
      • Kashiwa-shi, Chiba, Japan, 277-8577
        • Recruiting
        • National Cancer Center Hospital East
        • Contact:
          • Phone Number: 04-7133-1111
    • Ehime
      • Matsuyama, Ehime, Japan, 791-0280
        • Recruiting
        • NHO Shikoku Cancer Center
        • Contact:
          • Phone Number: 089-999-1111
      • Matsuyama, Ehime, Japan, 791-0280
        • Recruiting
        • NHO Himeji Medical Center
        • Contact:
          • Phone Number: 81 79-225-3211
    • Hokkaido
      • Sapporo, Hokkaido, Japan, 003-0804
        • Recruiting
        • National Hospital Organization Hokkaido Cancer Center
        • Contact:
          • Phone Number: +81-11-811-9111
    • Hyōgo
      • Akashi, Hyōgo, Japan, 673-8558
        • Recruiting
        • Hyogo Cancer Center
        • Contact:
          • Phone Number: +81-78-929-1151
    • Ishikawa-ken
      • Kanazawa, Ishikawa-ken, Japan, 920-8641
        • Recruiting
        • Kanazawa University Hospital
        • Contact:
          • Phone Number: 076-265-2000
    • Kanagawa
      • Sagamihara, Kanagawa, Japan, 252-0375
        • Recruiting
        • Kitasato University Hospital
        • Contact:
          • Phone Number: 042-778-8111
      • Yokohama, Kanagawa, Japan, 241-8515
        • Recruiting
        • Kanagawa Cancer Center
        • Contact:
          • Phone Number: 045-520-2222
    • Kyoto
      • Kyoto, Kyoto, Japan, 602-8566
        • Recruiting
        • University Hospital, Kyoto Prefectural University of Medicine
        • Contact:
          • Phone Number: +81-75-251-5111
    • Miyagi
      • Sendai, Miyagi, Japan, 980-8574
        • Recruiting
        • Tohoku University Hospital
        • Contact:
          • Phone Number: 022-717-7000
      • Sendai, Miyagi, Japan, 981-0914
        • Recruiting
        • Sendai Kousei Hospital
        • Contact:
          • Phone Number: +81-22-728-8000
    • Nara
      • Kashihara-shi, Nara, Japan, 634-8522
        • Recruiting
        • Nara Medical University Hospital
        • Contact:
          • Phone Number: 0744-22-3051
    • Niigata
      • Niigata, Niigata, Japan, 951-8566
        • Recruiting
        • Niigata Cancer Center
        • Contact:
          • Phone Number: 025-266-5111
    • Osaka
      • Hirakata-shi, Osaka, Japan, 573-1191
        • Recruiting
        • Kansai Medical University Hospital
        • Contact:
          • Phone Number: 072-804-0101
      • Osakasayama-shi, Osaka, Japan, 589-8511
        • Recruiting
        • Kindai University Hospital
        • Contact:
          • Phone Number: 072-366-0221
    • Saitama
      • Hidaka, Saitama, Japan, 350-1298
        • Recruiting
        • Saitama Medical University International Medical Center
        • Contact:
          • Phone Number: 042-984-4111
    • Shizuoka
      • Nagaizumi-chō, Shizuoka, Japan, 411-8777
        • Recruiting
        • Shizuoka Cancer Center
        • Contact:
          • Phone Number: 055-989-5222
    • Tokyo
      • Chuo Ku, Tokyo, Japan, 104-0045
        • Recruiting
        • National Cancer Center Hospital
        • Contact:
          • Phone Number: +81-3-3542-2511
      • Koto-Ku, Tokyo, Japan, 135-8550
        • Recruiting
        • Cancer Institute Hospital of JFCR
        • Contact:
          • Phone Number: +81-3-3520-0111
    • Wakayama
      • Wakayama, Wakayama, Japan, 641-8510
        • Recruiting
        • Wakayama Medical University Hospital
        • Contact:
          • Phone Number: 073-447-2300
      • Amsterdam, Netherlands, 1066 CX
        • Active, not recruiting
        • Antoni van Leeuwenhoek
      • Groningen, Netherlands, 9713GZ
        • Active, not recruiting
        • Universitair Medisch Centrum Groningen
      • Maastricht, Netherlands, 6229
        • Active, not recruiting
        • Maastricht University Medical Center P. Debyelaan 25
      • Nijmegen, Netherlands, 6525 GA
        • Active, not recruiting
        • Radboudumc
    • Netherlands
      • Amsterdam, Netherlands, Netherlands, 1081BT
        • Active, not recruiting
        • Amsterdam UMC, Locatie VUMC
      • Rotterdam, Netherlands, Netherlands, 3015AA
        • Active, not recruiting
        • Erasmus Medisch Centrum
    • Auckland
      • Grafton, Auckland, New Zealand, 1023
        • Active, not recruiting
        • Auckland City Hospital - Cancer and Blood Research
      • Gdansk, Poland, 80-214
        • Active, not recruiting
        • Klinika Onkologii I Radioterapii UCK
      • Lublin, Poland, 29-609
        • Active, not recruiting
        • INSTYTUT GENETYKI I IMMMUNOLOGII GENIM sp. z o.o.
      • Poznan, Poland, 60-693
        • Active, not recruiting
        • Med-Polonia Sp. z o.o.
      • Skorzewo, Poland, 60-185
        • Active, not recruiting
        • Aidport Sp. z o.o.
    • Puerto Rico
      • San Juan, Puerto Rico, Puerto Rico, 00909
        • Active, not recruiting
        • Pan American Center for Oncology Trials
      • Singapore, Singapore, 168583
        • Active, not recruiting
        • National Cancer Centre Singapore
      • Singapore, Singapore, 574623
        • Active, not recruiting
        • Icon Cancer Centre
    • Singapore
      • Singapore, Singapore, Singapore, 119074
        • Active, not recruiting
        • National University Hospital
      • Cheongju-si, South Korea, 28644
        • Active, not recruiting
        • Chungbuk National University Hospital
      • Hwasun, South Korea, 58128
        • Active, not recruiting
        • Chonnam National University Hwasun Hospital
      • Seoul, South Korea, 02841
        • Active, not recruiting
        • Korea University Anam Hospital
      • Seoul, South Korea, 06351
        • Active, not recruiting
        • Samsung Medical Center
      • Seoul, South Korea, 03722
        • Active, not recruiting
        • Severance Hospital, Yonsei University Health System
    • Suwon-si
      • Gyeonggi-do, Suwon-si, South Korea, 16499
        • Active, not recruiting
        • Ajou University Hospital
      • Barcelona, Spain, 08041
        • Active, not recruiting
        • Hospital de la Santa Creu i Sant Pau
    • A Coruña
      • A Coruña, A Coruña, Spain, 15006
        • Active, not recruiting
        • Complejo Hospitalario Universitario A Coruña
    • Barcelona
      • Barcelona, Barcelona, Spain, 08036
        • Recruiting
        • Hospital Clinic de Barcelona
        • Contact:
      • Barcelona, Barcelona, Spain, 08028
        • Active, not recruiting
        • Hospital Universitari Dexeus
      • Barcelona, Barcelona, Spain, 08035
        • Active, not recruiting
        • Hospital Universitari Vall d'Hebron - VHIO
      • Barcelona, Barcelona, Spain, 08908
        • Active, not recruiting
        • ICO l'Hospitalet - Hospital Duran i Reynals
    • Cádiz
      • Jerez de la Frontera, Cádiz, Spain, 11407
        • Active, not recruiting
        • Hospital de Especialidades de Jerez de la Frontera
    • Jaén
      • Jaén, Jaén, Spain, 23007
        • Active, not recruiting
        • Hospital Universitario Ciudad de Jaen
    • Las Palmas
      • Las Palmas de Gran Canaria, Las Palmas, Spain, 35016
        • Active, not recruiting
        • Complejo Hospitalario Universitario Insular-Materno Infantil
    • Madrid
      • Fuencarral-El Pardo, Madrid, Spain, 28046
        • Active, not recruiting
        • Hospital Universitario La Paz
      • Madrid, Madrid, Spain, 28040
        • Active, not recruiting
        • Hospital Universitario Clinico San Carlos
      • Madrid, Madrid, Spain, 28007
        • Active, not recruiting
        • Hospital General Universitario Gregorio Marañon
      • Madrid, Madrid, Spain, 28034
        • Active, not recruiting
        • Hospital Universitario Ramon y Cajal
      • Madrid, Madrid, Spain, 28050
        • Active, not recruiting
        • Hospital Universitario HM Madrid Sanchinarro
      • Majadahonda, Madrid, Spain, 28222
        • Active, not recruiting
        • Hospital Universitario Puerta de Hierro Majadahonda
    • Málaga
      • Málaga, Málaga, Spain, 29010
        • Active, not recruiting
        • Hospital Regional Universitario de Malaga
    • Sevilla
      • Seville, Sevilla, Spain, 41013
        • Active, not recruiting
        • Hospital Universitario Virgen del Rocio
    • Valencia
      • Valencia, Valencia, Spain, 46026
        • Active, not recruiting
        • Hospital Universitari i Politecnic La Fe
      • Basel, Switzerland, 4031
        • Active, not recruiting
        • Universitätsspital Basel
      • Fribourg, Switzerland, 1708
        • Active, not recruiting
        • HFR Fribourg/Kantonsspital Fribourg
      • Sankt Gallen, Switzerland, 9000
        • Active, not recruiting
        • HOCH Health Ostschweiz- Kantonsspital St. Gallen
      • Sankt Gallen, Switzerland, 9000
        • Active, not recruiting
        • Kantonsspital St. Gallen
      • Taipei, Taiwan, 110
        • Active, not recruiting
        • Taipei Medical University Hospital
      • Taoyuan, Taiwan, 333
        • Active, not recruiting
        • Chang Gung Medical Foundation Linkou
    • Taiwan
      • Kaohsiung, Taiwan, Taiwan, 100
        • Active, not recruiting
        • Kaohsiung Medical University Chung-Ho Memorial Hospital
      • Tainan, Taiwan, Taiwan, 704
        • Active, not recruiting
        • National Cheng Kung University Hospital
      • Taipei, Taiwan, Taiwan, 10002
        • Active, not recruiting
        • National Taiwan University Hospital
      • London, United Kingdom, W3 2QG
        • Active, not recruiting
        • Royal Free Hospital
      • Manchester, United Kingdom, M20 4BX
        • Active, not recruiting
        • The Christie NHS Foundation Trust
    • Great London
      • London, Great London, United Kingdom, EC1A7BE
        • Active, not recruiting
        • Barts Hospital
      • London, Great London, United Kingdom, NW12PG
        • Active, not recruiting
        • University College London Hospital
    • Greater London
      • London, Greater London, United Kingdom, SW3 6JJ
        • Active, not recruiting
        • Royal Marsden Hospital-London
    • Merseyside
      • Liverpool, Merseyside, United Kingdom, L7 8YA
        • Active, not recruiting
        • The Clatterbridge Cancer Centre
    • Nottinghamshire
      • Nottingham, Nottinghamshire, United Kingdom, NG51PB
        • Active, not recruiting
        • Nottingham University Hospitals City Campus
    • Surrey
      • Sutton, Surrey, United Kingdom, SM2 5PT
        • Active, not recruiting
        • Royal Marsden Hospital-Sutton
    • West Midlands
      • Birmingham, West Midlands, United Kingdom, B95SS
        • Active, not recruiting
        • Birmingham Heartlands Hospital
    • Alabama
      • Birmingham, Alabama, United States, 35243
        • Active, not recruiting
        • Alabama Oncology
    • California
      • Loma Linda, California, United States, 92408
        • Active, not recruiting
        • Loma Linda University
      • Long Beach, California, United States, 90806
        • Active, not recruiting
        • MemorialCare Long Beach Medical Center
      • Orange, California, United States, 92868
        • Recruiting
        • UC Irvine Health
    • Colorado
      • Colorado Springs, Colorado, United States, 80909
        • Active, not recruiting
        • UCHealth Memorial Hospital Central
    • Connecticut
      • New Haven, Connecticut, United States, 06519
        • Active, not recruiting
        • Yale University, Smillow Cancer Center
    • Florida
      • Fort Myers, Florida, United States, 33901
        • Active, not recruiting
        • Florida Cancer Specialists & Research Institute - South
      • Plantation, Florida, United States, 33322
        • Active, not recruiting
        • BRCR Global
      • St. Petersburg, Florida, United States, 33705
        • Active, not recruiting
        • Florida Cancer Specialists & Research Institute - North
      • Stuart, Florida, United States, 34994
        • Active, not recruiting
        • Cleveland Clinic Martin North
      • West Palm Beach, Florida, United States, 33401
        • Active, not recruiting
        • Florida Cancer Specialists & Research Institute - East
    • Georgia
      • Athens, Georgia, United States, 30607
        • Active, not recruiting
        • University Cancer and Blood Center
      • Atlanta, Georgia, United States, 30322
        • Active, not recruiting
        • Winship Cancer Institute
      • Atlanta, Georgia, United States, 30318
        • Active, not recruiting
        • Piedmont Healthcare, Inc
    • Illinois
      • Chicago, Illinois, United States, 60612
        • Active, not recruiting
        • University of Illinois Cancer Center
      • Chicago, Illinois, United States, 60637
        • Active, not recruiting
        • University of Chicago Medical Center
      • Chicago, Illinois, United States, 60607
        • Active, not recruiting
        • Rush University Medical Center
    • Indiana
      • Indianapolis, Indiana, United States, 46250
        • Active, not recruiting
        • Community Health Network
    • Iowa
      • Bettendorf, Iowa, United States, 52722
        • Active, not recruiting
        • University of Iowa Health Care Cancer Services Quad Cities
      • Iowa City, Iowa, United States, 52242
        • Active, not recruiting
        • University of Iowa Hospitals & Clinics
      • Waukee, Iowa, United States, 50263
        • Active, not recruiting
        • University of Iowa Health Care, Mission Cancer + Blood
    • Kansas
      • Westwood, Kansas, United States, 66205
        • Active, not recruiting
        • The University of Kansas Cancer Center
    • Maryland
      • Baltimore, Maryland, United States, 21201
        • Active, not recruiting
        • University of Maryland Greenebaum Comprehensive Cancer Center.
      • Baltimore, Maryland, United States, 21224
        • Active, not recruiting
        • Johns Hopkins University of Medicine
    • Michigan
      • Ann Arbor, Michigan, United States, 48106
        • Active, not recruiting
        • Trinity Health Ann Arbor Hospital
      • Detroit, Michigan, United States, 48201
        • Active, not recruiting
        • Karmanos Cancer Institute
      • Detroit, Michigan, United States, 48202
        • Active, not recruiting
        • Brigitte Harris Cancer Pavilion BHCP
    • Missouri
      • St Louis, Missouri, United States, 63110
        • Active, not recruiting
        • Washington University School of Medicine - Siteman Cancer Center
    • Montana
      • Billings, Montana, United States, 59102
        • Active, not recruiting
        • St. Vincent Frontier Cancer Center
    • Nevada
      • Henderson, Nevada, United States, 89014
        • Active, not recruiting
        • Comprehensive Cancer Centers of Nevada
    • New Hampshire
      • Lebanon, New Hampshire, United States, 03756
        • Active, not recruiting
        • Dartmouth-Hitchcock Medical Center
    • New Jersey
      • Hackensack, New Jersey, United States, 07601
        • Active, not recruiting
        • John Theurer Cancer Center at Hackensack UMC
      • Morristown, New Jersey, United States, 07960
        • Active, not recruiting
        • Morristown Medical Center (MMCORC)
    • New York
      • Buffalo, New York, United States, 14263
        • Active, not recruiting
        • Roswell Park Cancer Institute
      • New York, New York, United States, 10065
        • Active, not recruiting
        • Memorial Sloan Kettering Cancer Center
      • The Bronx, New York, United States, 10461
        • Active, not recruiting
        • Montefiore Medical Center
    • North Carolina
      • Chapel Hill, North Carolina, United States, 27599
        • Active, not recruiting
        • UNC Lineberger Comprehensive Cancer Center at University of North Carolina
    • Ohio
      • Cincinnati, Ohio, United States, 45220
        • Active, not recruiting
        • TriHealth Cancer & Blood Institute Research
      • Maumee, Ohio, United States, 43537
        • Active, not recruiting
        • Taylor Cancer Research Center
    • Oregon
      • Eugene, Oregon, United States, 97401
        • Active, not recruiting
        • Oncology Associates of Oregon PC
    • Pennsylvania
      • Hershey, Pennsylvania, United States, 17033
        • Active, not recruiting
        • Penn State Milton S. Hershey Medical Center
    • South Dakota
      • Aberdeen, South Dakota, United States, 57401
        • Active, not recruiting
        • Avera Saint Luke's Hospital
      • Sioux Falls, South Dakota, United States, 57105
        • Active, not recruiting
        • Avera Cancer Institute
    • Tennessee
      • Nashville, Tennessee, United States, 37203
        • Active, not recruiting
        • SCRI Oncology Partners - Tennessee
    • Texas
      • Austin, Texas, United States, 78745
        • Active, not recruiting
        • Texas Oncology - South Austin
      • Dallas, Texas, United States, 75251
        • Active, not recruiting
        • Texas Oncology Dallas
      • Houston, Texas, United States, 77030
        • Active, not recruiting
        • MD Anderson Cancer Center
      • Irving, Texas, United States, 75063
        • Active, not recruiting
        • Cancer Care Centers of Brevard
      • Irving, Texas, United States, 75063
        • Active, not recruiting
        • US Oncology Investigational Products Center (IPC)
      • The Woodlands, Texas, United States, 77380
        • Active, not recruiting
        • Texas Oncology - Gulf Coast
    • Utah
      • Salt Lake City, Utah, United States, 84112
        • Active, not recruiting
        • Huntsman Cancer Institute
      • Salt Lake City, Utah, United States, 84106
        • Active, not recruiting
        • Utah Cancer Specialists
    • Virginia
      • Fairfax, Virginia, United States, 22031
        • Active, not recruiting
        • Virginia Cancer Specialists

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • At least 18 years old and has provided informed consent.
  • Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1.
  • Pathologically confirmed NSCLC, either locally advanced or metastatic, not amenable to curative surgery or radiotherapy.
  • Measurable disease per RECIST v1.1.
  • Adequate organ function (bone marrow, liver, kidney, coagulation).
  • One to two prior lines of therapy including an anti-PD-1/anti-PD(L)-1 agent and platinum-based chemotherapy.
  • Documented RAS mutation status, defined as Nonsynonymous mutations in KRAS, NRAS, or HRAS at codons 12, 13, or 61 (G12, G13, or Q61).
  • Able to take oral medications.

Exclusion Criteria:

  • Prior therapy with direct RAS-targeted therapy or docetaxel.
  • Untreated central nervous system (CNS) metastases.
  • Medically significant comorbidities (significant cardiovascular disease, lung disease, or impaired GI function).
  • Ongoing anticancer therapy.
  • Pregnant or breastfeeding.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: daraxonrasib

study drug

oral tablets

Active Comparator: docetaxel

Patients randomized to the comparator control arm will receive docetaxel as the standard of care therapy.

intravenous (IV) infusion

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Progression free survival (PFS) per Blinded Independent Central Review (BICR) in the RAS G12X-C population (i.e RAS G12X excluding G12C)
Time Frame: Up to approximately 4 years

PFS is defined as the time from randomization until disease progression or death from any cause, whichever occurs first. Progression is per response evaluation criteria in solid tumors (RECIST) v1.1 and as assessed by BICR.

Up to approximately 4 years
Overall survival (OS) in the RAS G12X-C population
Time Frame: Up to approximately 4 years

OS is defined as the time from randomization until death from any cause.

Up to approximately 4 years

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
PFS in the RAS (MUT) population per BICR
Time Frame: Up to approximately 4 years

PFS is defined as time from randomization until disease progression or death from any cause, whichever occurs first. Progression is per RECIST v1.1 as assessed by BICR.

Up to approximately 4 years
OS in the RAS (MUT) population
Time Frame: up to approximately 4 years

OS is defined as time from randomization until death from any cause.

up to approximately 4 years
Objective response per BICR in the RAS (G12X-C) and RAS (MUT) populations
Time Frame: Up to approximately 4 years

Objective response of partial response (PR) or complete response (CR) per RECIST v1.1 as assessed by BICR.

Up to approximately 4 years
PFS per Investigator in the RAS (G12X-C) and RAS (MUT) populations
Time Frame: Up to approximately 4 years

PFS is defined as time from randomization until disease progression or death from any cause, whichever occurs first. Progression is per RECIST v1.1 as assessed by Investigator.

Up to approximately 4 years
Objective response per Investigator in the RAS (G12X-C) and RAS (MUT) populations
Time Frame: Up to approximately 4 years

Objective response of PR or CR per RECIST v1.1 as assessed by Investigator.

Up to approximately 4 years
Duration of response (DOR) per Investigator and per BICR in the RAS (G12X-C) and RAS (MUT) populations
Time Frame: Up to approximately 4 years

DOR is defined as time from first evidence of objective response (PR or CR) to disease progression or death due to any cause, whichever occurs first, as assessed by Investigator and by BICR.

Up to approximately 4 years
Time to response (TTR) per Investigator and per BICR in the RAS (G12X-C) and RAS (MUT) populations
Time Frame: Up to approximately 4 years

TTR is defined as time from randomization to first evidence of objective response (PR or CR), as assessed by Investigator and by BICR.

Up to approximately 4 years
Treatment effect on quality of life (QoL) using EORTC QLQ-LC13 In the RAS (G12X-C) and RAS (MUT) populations
Time Frame: Up to approximately 4 years

Time to deterioration (TTD) in selected symptoms (dyspnea, chest pain, cough) defined as the time from randomization to the first onset of 10 points or more deterioration from baseline in the corresponding symptom scales (dyspnea, chest pain, cough) on European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire LC-13 (EORTC QLQ-LC13).

Change from baseline on EORTC QLQ-LC13 in symptom scales (dyspnea, cough, chest pain).

Up to approximately 4 years
Treatment effect on quality of life (QoL) using EORTC QLQ-C30 In the RAS (G12X-C) and RAS (MUT) populations
Time Frame: Up to approximately 4 years

Change from baseline in global quality of life score from European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire C30 (EORTC QLQ-C30) questionnaire.

Change from baseline on EORTC QLQ-C30 functioning domains (physical role, cognitive, emotional, social).

Up to approximately 4 years
Safety and tolerability in the RAS (G12X-C) and RAS (MUT) population
Time Frame: Up to approximately 4 years

Incidence of treatment emergent adverse events (TEAEs), treatment related adverse events (TRAEs), serious adverse events (SAEs), changes in vital signs and clinical laboratory tests.

Up to approximately 4 years
PK characterization of daraxonrasib In the RAS (MUT) population
Time Frame: Up to approximately 4 years

Predose and post-dose blood concentrations of daraxonrasib over time.

Up to approximately 4 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 6, 2025

Primary Completion (Estimated)

December 1, 2027

Study Completion (Estimated)

December 1, 2030

Study Registration Dates

First Submitted

March 10, 2025

First Submitted That Met QC Criteria

March 10, 2025

First Posted (Actual)

March 18, 2025

Study Record Updates

Last Update Posted (Actual)

November 6, 2026

Last Update Submitted That Met QC Criteria

November 4, 2026

Last Verified

July 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • RMC-6236-301

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

Yes

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.